top of page
Search

Oral presentation at ESGCT 22

  • Oct 12, 2022
  • 1 min read

Updated: Oct 14, 2022

Presentation of poster 504 by Dr. J. Doms ART-TG at ESGCT

Vaccine technologies and Infectious Diseases. Rrom Pentland 8:30-10:40

"A non-viral CRISPR/Cas9 gene-editing approach to express anti-HIV broadly-neutralizing antibodies in human B cells for HIV immunotherapy" #esgct #genetherapy #inserm


ree


 
 
 

Comments


ART-TG
Inserm US35
30 rue H. Desbruères
91100 Corbeil-Essonnes
France

Director :
Anne Galy PhD

Copyright @ ART-TG 2021

bottom of page